A Randomized, Open Label, Rater Blind, Flexible Dose Multi-Center Study Comparing The Efficacy And Safety Of Intramuscular Ziprasidone With Haloperidol For Three Days In Patients With Agitation Of Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 24 Jul 2015
At a glance
- Drugs Ziprasidone (Primary) ; Haloperidol
- Indications Agitation; Schizophrenia
- Focus Therapeutic Use
- 14 Feb 2013 Primary endpoint 'Brief-Psychiatric-Rating-Scale' has been met.
- 06 Jun 2010 Results have been presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum.
- 13 Oct 2009 Actual patient number (376) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History